gip/glp-1 tirzepatide Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Tirzepatide (TZP) differentially induces internalization

doi: 10.1161/CIRCRESAHA.117.311586

Read the full terms and conditions and returns policy before paying

Our team prioritizes patient safety and comfort

Meanwhile, leading firms in China, such as Jiangsu Hengrui Pharmaceuticals, and in Europe, notably Sandoz, have also announced plans to market generic semaglutide

By activating the receptors for both GLP-1 and GIP, tirzepatide helps your body in several ways: Enhances insulin secretion in response to meals Reduces glucose production by the liver Slows stomach emptying, leading to increased feelings of fullness These combined effects help regulate blood sugar and curb appetite, making it easier for patients to reduce food intake and achieve sustainable weight loss